We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

AVAI: Atrial Ventricular Arrythmia Incidence (AVAI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00832975
Recruitment Status : Completed
First Posted : January 30, 2009
Results First Posted : March 3, 2015
Last Update Posted : December 2, 2016
Information provided by (Responsible Party):
St. Jude Medical

January 29, 2009
January 30, 2009
February 17, 2015
March 3, 2015
December 2, 2016
December 2008
February 2013   (Final data collection date for primary outcome measure)
Slow Ventricular Tachycardia Episodes Devices Detected (Between 120-150 Bpm and > 30sec) Atrial Fibrillation (AF) Episodes Devices Detected (> 30 Sec) [ Time Frame: 24 months ]
Slow Ventricular Tachycardia episodes will be considered as a tachycardia episodes detected by the device between 120-150 bpm and with more than 30sec of duration AF Episodes will be considered only when their duration is >30sec
Slow Ventricular Tachycardia Episodes devices detected (between 120-150 bpm and > 30sec) AF Episodes devices detected (> 30 sec) [ Time Frame: 24 months ]
Complete list of historical versions of study NCT00832975 on ClinicalTrials.gov Archive Site
Cardiovascular Mortality Hospitalization Rate Due to Cardiovascular Reasons or Heart Failure [ Time Frame: 24 months ]
Cardiovascular Mortality Hospitalization rate due to cardiovascular reasons or heart failure Slow Ventricular Tachycardia and Atrial fibrillation Episodes Cardiac Symptoms [ Time Frame: 24 months ]
Not Provided
Not Provided
AVAI: Atrial Ventricular Arrythmia Incidence
Study of Slow Ventricular Tachycardia and Atrial Fibrillation Incidence Documented by Intracardiac Electrogram in Patients Implanted With an Implantable Cardiac Device (ICD) .
The purpose of this observational study is to collect data regarding the population of patients implanted with St. Jude Medical ICD.
The purpose of this observational study is to collect data regarding the population of patients implanted with a St. Jude Medical ICD. Data regarding Slow Ventricular Tachycardia Episodes, Atrial Fibrillation Episodes and the devices programmed parameters will be collected during two years after the implant.
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients implanted with a St. Jude Medical ICD
  • Ventricular Tachycardia
  • Atrial Fibrillation
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
December 2013
February 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient has been implanted with a St Jude Medical ICD, mono,bicameral or cardiac resynchronization therapy - Defibrillator (CRT-D) according the American College of Cardiology (ACC), American Heart Association (AHA), National Standards for Physical Education (NASPE) guidelines. (min. 24 hours - max. 2 months)
  • Patient has signed the study specific Informed consent document.
  • Patient is older than 18 years of age

Exclusion Criteria:

  • Patient has a permanent Atrial Fibrillation
  • Patient has a documented slow ventricular Tachycardia Episodes previous to the ICD implant.
  • Patient not programed with a ventricular Tachycardia (VT) zone upper than 120 bpm.
  • Patient requires cardiac resynchronization
  • Patient has Brugada Syndrome
  • Patient has long QT Syndrome
  • Patient has a device replacement;
  • Patient is pregnant or nursing
  • Patient is unable to attend the follow-up visits
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
St. Jude Medical
St. Jude Medical
Not Provided
Principal Investigator: Ignacio Fernández Lozano, PhD. Hospital Universitario Puerta de Hierro
Principal Investigator: Javier Alzueta, PhD Hospital Clinico Universitario Virgen de la Victoria
St. Jude Medical
October 2016